Sight Sciences, Inc.
SGHT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $120 | $138 | $185 | $261 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $11 | $14 | $15 | $9 |
| Inventory | $6 | $8 | $6 | $3 |
| Other Curr. Assets | $2 | $3 | $3 | $0 |
| Total Curr. Assets | $140 | $163 | $210 | $277 |
| Property Plant & Equip (Net) | $3 | $3 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $0 | $0 |
| Total NC Assets | $3 | $4 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $143 | $167 | $213 | $280 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $3 | $3 |
| Short-Term Debt | $0 | $2 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $5 | $7 | $6 |
| Total Curr. Liab. | $15 | $12 | $18 | $14 |
| LT Debt | $39 | $32 | $33 | $33 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $2 | $1 | $1 |
| Total NC Liab. | $40 | $34 | $35 | $35 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $2 | $2 |
| Total Liabilities | $55 | $46 | $53 | $48 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$346 | -$295 | -$239 | -$153 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $88 | $120 | $160 | $232 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $143 | $167 | $213 | $280 |
| Net Debt | -$81 | -$104 | -$152 | -$228 |